Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(43%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
14%
Ph phase_3
2
29%
Ph phase_2
4
57%

Phase Distribution

1

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(3)

Detailed Status

Active, not recruiting3
Completed3
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 24 (57.1%)
Phase 32 (28.6%)

Trials by Status

enrolling_by_invitation114%
active_not_recruiting343%
completed343%

Recent Activity

3 active trials
Showing 5 of 7
active_not_recruitingphase_3

A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)

NCT04573023
enrolling_by_invitationphase_3

An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects

NCT05594992
active_not_recruitingphase_2

An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II

NCT04348136
active_not_recruitingphase_2

An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II

NCT03708965
completedphase_2

A Study of JR-141 in Patients With Mucopolysaccharidosis II (BR21)

NCT03359213
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04573023Phase 3

A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)

Active Not Recruiting
NCT05594992Phase 3

An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects

Enrolling By Invitation
NCT04348136Phase 2

An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II

Active Not Recruiting
NCT03708965Phase 2

An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II

Active Not Recruiting
NCT03359213Phase 2

A Study of JR-141 in Patients With Mucopolysaccharidosis II (BR21)

Completed
NCT03568175Phase 2

A Study of JR-141 in Patients With Mucopolysaccharidosis II

Completed
NCT03128593Phase 1

A Study of JR-141 in Patients With Mucopolysaccharidosis Type II

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7